BIOLASE, Inc. (BIOL): Volume dana dhuwit perusahaan

Simbol resmi perusahaan Biolase, Inc. (BIOL)

A stable staff of R&D experts ensures growth, as confirmed by the cash assets figure, where the current metric equals 0.01. The success of BIOLASE, Inc. (BIOL) is based on an impeccable reputation in laser dentistry. However, expansion relies on the openness of foreign markets, as trade barriers and electronic logistics disruptions could limit the inflow of liquidity into the company.

Dana dhuwit perusahaan: Biolase Inc. (BIOL) kanggo 04.07.2022 - 04.08.2024

Ringkesan rincian data analitis BIOLASE Inc. (BIOL)

- kuotasi lan prakiraan analis:
Analisis wiwitan perusahaan:Biolase Inc. BIOL
Produk merek BIOLASE

This indicator determines the volume of liquid assets forming the company's financial buffer against market volatility. By analyzing the history of cash holdings, an investor assesses the balance between security and capital efficiency. The metric measures the business's ability to cover liabilities without incurring external debt. For BIOLASE, Inc. (BIOL), such reserves ensure stability while scaling the laser systems ecosystem. High margins on replacement tips create a steady cash flow, strengthening the issuer's fundamental resilience.

Analisis perusahaan pesaing

Volume dana dhuwit perusahaan BSX|Dana dhuwit perusahaan EW (Edwards Lifesciences Corporation)|Dana dhuwit perusahaan ResMed RMD|Volume dana dhuwit perusahaan Insulet Corp PODD|ZBH: Dhuwit awis perusahaan|Sisa dhuwit perusahaan COO (CooperVision)|ALGN (Align Technology, Inc.) - Dhuwit awis perusahaan|Globus Medical, Inc. - Sisa dhuwit perusahaan|TMDX (TransMedics Group Inc) - Volume dana dhuwit perusahaan|Cadangan dhuwit perusahaan Alphatec Holdings ATEC|Dana dhuwit perusahaan CryoLife (AORT)|Enovis Corporation (ENOV) - Posisi dhuwit perusahaan|Integra LifeSciences Inc. - Dhuwit awis perusahaan|Volume dana dhuwit perusahaan Establishment Labs ESTA|Beta Bionics, Inc. - Volume dana dhuwit perusahaan|Aset likuid perusahaan IRADIMED Corp IRMD|Embecta (EMBC) - Dana dhuwit perusahaan|Total volume dana dhuwit perusahaan TNDM (Tandem Corp)|Dana dhuwit perusahaan axogeninc.com|Dhuwit awis perusahaan SI-BONE, Inc. (SIBN)|Volume dana dhuwit perusahaan OFIX|Bioventus Corp - Dhuwit awis lan setara dhuwit awis perusahaan|Dana dhuwit perusahaan orthopediatrics.com KIDS|TMCI: Dhuwit awis lan setara dhuwit awis perusahaan|SRTA: Dhuwit awis perusahaan|Carlsmed Inc - Gunggung dana dhuwit perusahaan|RxSight (RXST) - Dana dhuwit perusahaan|Dhuwit awis perusahaan ClearPoint|Dhuwit awis perusahaan STXS|Cadangan dhuwit perusahaan Neuronetics, Inc. STIM|Volume dana dhuwit perusahaan SGHT|Dhuwit awis perusahaan Orchestra BioMed OBIO|Dana dhuwit perusahaan Anika Therapeutics Inc. ANIK|NSPR (InspireMD) - Total volume dana dhuwit perusahaan|ZJYL - Dana dhuwit perusahaan|VANI (vivani.com) - Dhuwit awis lan setara dhuwit awis perusahaan|XTNT (Xtant Medical Inc) - Dhuwit awis perusahaan|Cadangan dhuwit perusahaan n1mtc.com (NMTC)|Dana dhuwit perusahaan modular-medical.com|Dhuwit awis lan setara dhuwit awis perusahaan MYO (Myomo)|Volume dana dhuwit perusahaan COCH|VVOS (Vivos Therapeutics, Inc) - Sisa dhuwit perusahaan|Dana dhuwit perusahaan envveno.com NVNO|SINT - Dhuwit awis perusahaan|Tenon Medical Inc. - Volume dana dhuwit perusahaan|LFWD: Dana dhuwit perusahaan|Autonomix (AMIX) - Dana dhuwit perusahaan|IVF - Aset likuid perusahaan|BBLG (bonebiologics.com) - Volume dana dhuwit perusahaan|Axonics, Inc. (AXNX) - Aset likuid perusahaan|Volume dana dhuwit perusahaan DYNT|Aset likuid perusahaan Paragon 28|Volume dana dhuwit perusahaan INVO (INVO Bioscience, Inc.)